Masaru Narabayashi

Nationwide Survey on Complementary and Alternative Medicine in Cancer Patients in Japan

Ichinosuke Hyodo, Noriko Amano, Kenji Eguchi et al. · Journal of Clinical Oncology · 2005 · 346 citations · Full text

Medicine, Oncology, Cancer Symptom Management +10

Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer

Yukinori Matsuo, Keiko Shibuya, Mitsuhiro Nakamura et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 194 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Toxicity Grading Criteria of the Japan Clinical Oncology Group

Kensei Tobinai, Akio Kohno, Yasuhiro Shimada et al. · Japanese Journal of Clinical Oncology · 1993 · 173 citations

Pharmacy, Oncology, Cancer Drug Toxicity Management +15

Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma

Kensei Tobinai, Yukio Kobayashi, Masaru Narabayashi et al. · Annals of Oncology · 1998 · 152 citations · Full text

Pharmacy, Hematology, Pharmacokinetics +16

Construction and validation of a practical prognostic index for patients with metastatic breast cancer.

Noboru Yamamoto, Toru Watanabe, Noriyuki Katsumata et al. · Journal of Clinical Oncology · 1998 · 143 citations

Medicine, Oncology, Chemotherapy +16